1,25(OH)2D3对结核激活的Th1细胞介导破骨细胞生成的影响及机制研究

基本信息
批准号:81371980
项目类别:面上项目
资助金额:70.00
负责人:张泽华
学科分类:
依托单位:中国人民解放军第三军医大学
批准年份:2013
结题年份:2017
起止时间:2014-01-01 - 2017-12-31
项目状态: 已结题
项目参与者:许建中,罗飞,邓墨渊,孙东,刘春雨,陈非凡,于博
关键词:
维生素D缺乏迟发型变态反应Th1细胞脊柱结核破骨细胞
结项摘要

Several studies confirmed that Vitamin D deficiency was associated with susceptibility to tuberculosis. We found that Vitamin D modulated the acquired immune response during mycobacterial infection by affecting the maturation and function of DCs. Th1 cells activation, increased IL-2 and IFN-γ secretion, severe bone destruction were also observed in spinal tuberculosis patients with Vitamin D deficiency. So we hypothesize that the effect of 1,25(OH)2D3 on TB-Th1-OC axis in osteoimmunology is concentration dependent.The mouse are divided into Vitamin D deficiency group, normal group and VDR knockout group. BCG and PPD are used to induce delayed type hypersensitivity, then lymphokine and lymphotactin in peripheral blood are tested by ELISA. Tuberculosis activiated Th1 cells are treated with gradient concentrations of 1,25(OH)2D3, immune associated genes are analyzed by Microarray, the secretion of IFN-γ,RANKL and TNF-α are tested by ELISA, the expression of IFN-γ mRNA is evalueated by real time-PCR and ChIP. Then Th1 cells and BMMs are co-cultured with gradient concentrations of 1,25(OH)2D3 using transwell, the influence and mechanism of 1,25(OH)2D3 on Th1 cell mediated osteoclastogenesis are evaluated using real time PCR,western blot, immunohistochemistry and SEM. These would contribute to reduce tuberculosis incidence and develop modulating immunity as a potential therapy for osteoarticular tuberculosis.

既往研究证实VD缺乏与结核易感性密切相关。课题组发现VD调节小鼠DC表型和功能来影响抗结核免疫;而VD缺乏脊柱结核患者Th1细胞活化,IFN-γ分泌增多,骨组织破坏重,机制不清。推测 1,25(OH)2D3在骨关节结核TB-Th1-OC骨免疫网络中的作用具有浓度依赖性。本项目设立小鼠VD缺乏、正常、VDR KO组,PPD诱发DTH,ELISA检测淋巴细胞因子、趋化因子表达;结核激活Th1细胞,梯度浓度1,25(OH)2D3干预,Microarray比较免疫靶基因表达差异,ELISA检测IFN-γ、RANKL和TNF-α水平,RT-PCR检测IFN-γmRNA表达,ChIP检测IFN-γ启动子区乙酰化水平;将Th1与BMMs共培养,采用基因与蛋白表达定量检测、免疫组化、SEM,探讨1,25(OH)2D3对Th1细胞介导OC生成的影响及机制,为完善结核病防治、骨关节结核免疫辅助治疗奠定基础。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Influencing factors of carbon emissions in transportation industry based on CD function and LMDI decomposition model: China as an example

Influencing factors of carbon emissions in transportation industry based on CD function and LMDI decomposition model: China as an example

DOI:10.1016/j.eiar.2021.106623
发表时间:2021
2

1例脊肌萎缩症伴脊柱侧凸患儿后路脊柱矫形术的麻醉护理配合

1例脊肌萎缩症伴脊柱侧凸患儿后路脊柱矫形术的麻醉护理配合

DOI:10.3870/j.issn.1001-4152.2021.10.047
发表时间:2021
3

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021
4

视网膜母细胞瘤的治疗研究进展

视网膜母细胞瘤的治疗研究进展

DOI:
发表时间:2018
5

Combining Spectral Unmixing and 3D/2D Dense Networks with Early-Exiting Strategy for Hyperspectral Image Classification

Combining Spectral Unmixing and 3D/2D Dense Networks with Early-Exiting Strategy for Hyperspectral Image Classification

DOI:10.3390/rs12050779
发表时间:2020

相似国自然基金

1

1,25(OH)2D3对类风湿关节炎成纤维滑膜细胞IL-22介导的RANKL表达及破骨细胞形成影响的可能机制研究

批准号:81301532
批准年份:2013
负责人:温鸿雁
学科分类:H0602
资助金额:23.00
项目类别:青年科学基金项目
2

耐多药脊柱结核患者MΦ-OC功能失调及1,25(OH)2D3调节机制研究

批准号:81772365
批准年份:2017
负责人:张泽华
学科分类:H0606
资助金额:55.00
项目类别:面上项目
3

1,25(OH)2D3 在抗皮肤和骨骼衰老中的作用机制研究

批准号:81200243
批准年份:2012
负责人:季吉
学科分类:H1902
资助金额:23.00
项目类别:青年科学基金项目
4

1,25(OH)2D3 通过调节ASAP2基因表达促进巨噬细胞胞葬作用的机制研究

批准号:81901656
批准年份:2019
负责人:陆明
学科分类:H1107
资助金额:20.00
项目类别:青年科学基金项目